
|Articles|June 1, 2003
Is it time to lower the PSA cut-point for biopsy?
Chicago-The traditional PSA cut-point of 4.0 ng/mL for recommending abiopsy to diagnose prostate cancer is controversial, and some researchershave recommended cut-points as low as 2.0 ng/mL. Two separate studies presentedat the AUA annual meeting here have found that cut-points of 2.5 or 2.6ng/mL may be more appropriate for determining the need for prostate biopsy.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
2
Choosing salvage therapy after prostate cancer focal ablation
3
Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5


















